Molecular profiling and genetic testing have revolutionised lung cancer treatment, says a doctor. They have enabled targeted ...

We might finally know the identity of the notorious killer, Jack the Ripper, and we might even have a DNA result for ...

New research at the University of Alberta may make it easier to diagnose serious diseases that disrupt the body's energy ...

Noah S. Kalman, MD, MBA, discusses the evolving role of molecular and genetic testing in thyroid cancer management.

Report Metric Details Base year considered 2023 Forecast period considered 2024-2029 Base year market size $19.

Two new studies represent a big step toward developing innovative molecular therapies capable of disrupting the ...

Using the Decipher Bladder test to determine each tumor’s molecular subtype, researchers found that NMIBC patients with ...

LAHORE: The University of Health Sciences (UHS) Lahore is all set to inaugurate its state-of-the-art diagnostic laboratory on ...

About Precise Molecular Residual Disease (MRD ... Myriad Genetics develops and offers genetic tests that help assess the risk of developing disease or disease progression and guide treatment decisions ...

Laboratories “announced that the company has entered into a binding offer to purchase all equity interests in Stilla ...

Myriad Genetics announces USPTO grants two new patents for its molecular residual disease assay: Salt Lake City Friday, February 7, 2025, 13:00 Hrs [IST] Myriad Genetics, Inc., a ...